Bosutinib versus imatinib in newly diagnosed chronic‐phase chronic myeloid leukaemia: results from the 24‐month follow‐up of the BELA trial
Brümmendorf, Tim H., Cortes, Jorge E., Souza, Cármino Antonio, Guilhot, Francois, Duvillié, Ladan, Pavlov, Dmitri, Gogat, Karïn, Countouriotis, Athena M., Gambacorti‐Passerini, Carlo
Published in British journal of haematology (01.01.2015)
Published in British journal of haematology (01.01.2015)
Get full text
Journal Article
High prevalence of iron deficiency in patients with acute decompensated heart failure
Cohen-Solal, Alain, Damy, Thibaud, Terbah, Mohamed, Kerebel, Sébastien, Baguet, Jean-Philippe, Hanon, Olivier, Zannad, Faiez, Laperche, Thierry, Leclercq, Christophe, Concas, Victor, Duvillié, Ladan, Darné, Bernadette, Anker, Stefan, Mebazaa, Alexandre
Published in European journal of heart failure (01.09.2014)
Published in European journal of heart failure (01.09.2014)
Get full text
Journal Article
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia
Gambacorti‐Passerini, Carlo, Cortes, Jorge E., Lipton, Jeff H., Dmoszynska, Anna, Wong, Raymond S., Rossiev, Victor, Pavlov, Dmitri, Gogat Marchant, Karin, Duvillié, Ladan, Khattry, Navin, Kantarjian, Hagop M., Brümmendorf, Tim H.
Published in American journal of hematology (01.10.2014)
Published in American journal of hematology (01.10.2014)
Get full text
Journal Article
Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France
Toledano, Alain, Luporsi, Elisabeth, Morere, Jean François, Scotté, Florian, Laribi, Kamel, Barrière, Jérôme, Huot-Marchand, Philippe, Duvillié, Ladan, Concas, Victor Hugo, Bugat, Roland
Published in Supportive care in cancer (01.01.2016)
Published in Supportive care in cancer (01.01.2016)
Get full text
Journal Article
Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First‐Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor‐Positive/HER2‐Negative Breast Cancer
Moy, Beverly, Neven, Patrick, Lebrun, Fabienne, Bellet, Meritxell, Xu, Binghe, Sarosiek, Tomasz, Chow, Louis, Goss, Paul, Zacharchuk, Charles, Leip, Eric, Turnbull, Kathleen, Bardy‐Bouxin, Nathalie, Duvillié, Ladan, Láng, István
Published in The oncologist (Dayton, Ohio) (01.04.2014)
Published in The oncologist (Dayton, Ohio) (01.04.2014)
Get full text
Journal Article
Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor‐Positive/HER2‐Negative Breast Cancer
Moy, Beverly, Neven, Patrick, Lebrun, Fabienne, Bellet, Meritxell, Xu, Binghe, Sarosiek, Tomasz, Chow, Louis, Goss, Paul, Zacharchuk, Charles, Leip, Eric, Turnbull, Kathleen, Bardy‐Bouxin, Nathalie, Duvillié, Ladan, Láng, István
Published in The oncologist (Dayton, Ohio) (01.04.2014)
Published in The oncologist (Dayton, Ohio) (01.04.2014)
Get full text
Journal Article
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study)
Luporsi, Elisabeth, Toledano, Alain, Spaeth, Dominique, Scotté, Florian, Espié, Marc, Perot, Stéphanie, Duvillié, Ladan, Pithois Merli, Isabelle, Bugat, Roland
Published in Supportive care in cancer (01.03.2017)
Published in Supportive care in cancer (01.03.2017)
Get full text
Journal Article
HIGH PREVALENCE OF IRON DEFICIENCY IN PATIENTS ADMITTED FOR ACUTE DECOMPENSATED HEART FAILURE: A FRENCH STUDY (CARDIOFER)
Cohen-Solal, Alain, Damy, Thibaud, Hanon, Olivier, Terbah, Mohamed, Laperche, Thierry, Kerebel, Sebastien, Zannad, Faiez, Baguet, Jean Philippe, Leclercq, Christophe, Concas, Victor, Duvillié, Ladan, Darné, Bernadette, Mebazaa, Alexandre
Published in Journal of the American College of Cardiology (01.04.2014)
Published in Journal of the American College of Cardiology (01.04.2014)
Get full text
Journal Article
Abstract A91: A phase I dose-escalation study of bosutinib plus capecitabine in selected advanced solid tumors
Isakoff, Steven, Wang, Ding, Campone, Mario, Calles, Antonio, Bardy-Bouxin, Nathalie, Duvillie, Ladan, Calvo, Emiliano
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Efficacy and Tolerability of Bosutinib and Imatinib in Older Versus Younger Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia–BELA Trial
Gambacorti-Passerini, Carlo, Brümmendorf, Tim H, Kim, Dong-Wook, Dyagil, Irina, Kantarjian, Hagop M, Pavlov, Dmitri, Gogat, Karin, Duvillie, Ladan, Shapiro, Mark, Cortes, Jorge E
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
BELA trial update: Bosutinib (BOS) versus imatinib (IM) in patients (pts) with newly diagnosed chronic phase chronic myeloid leukemia (CP CML) after 30 months of follow-up
Gambacorti-Passerini, Carlo, Lipton, Jeffrey Howard, Tee, Goh Yeow, Casado, Luis Felipe, Zaritskey, Andrey, le Coutre, Philipp D., Duvillie, Ladan, Pavlov, Dmitri, Countouriotis, Athena Maria, Byrne, Jennifer
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
The Incidence of Bcr-Abl Mutations and Their Impact on Clinical Outcome in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Bosutinib Versus Imatinib in the BELA Trial
Kim, Dong-Wook, Cortes, Jorge E, Maslyak, Zvenyslava, Wong, Raymond, Duvillie, Ladan, Powell, Christine, Countouriotis, Athena, Brümmendorf, Tim H
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Bosutinib Versus Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia – BELA Trial: 24-Month Follow-up
Cortes, Jorge E, Maru, Anish, Souza, Carmino Antonio Antonio De, Guilhot, François, Duvillie, Ladan, Powell, Christine, Countouriotis, Athena, Gambacorti-Passerini, Carlo
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Assessment of Early Molecular Response As a Predictor of Long-Term Clinical Outcomes in the Phase 3 BELA Study
Brümmendorf, Tim H, Kantarjian, Hagop M., Gambacorti-Passerini, Carlo, Guilhot, Francois, Akard, Luke, Doshi, Vaishali, Lipton, Jeff H, Pavlov, Dmitri, Gogat, Karin, Duvillie, Ladan, Shapiro, Mark, Cortes, Jorge E
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article